Whitehawk Therapeutics (WHWK) Gross Profit (2022 - 2025)
Historic Gross Profit for Whitehawk Therapeutics (WHWK) over the last 5 years, with Q1 2025 value amounting to $6.4 million.
- Whitehawk Therapeutics' Gross Profit rose 3582.22% to $6.4 million in Q1 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year decrease of 4142.13%. This contributed to the annual value of $23.0 million for FY2024, which is 656.3% up from last year.
- Whitehawk Therapeutics' Gross Profit amounted to $6.4 million in Q1 2025, which was up 3582.22% from $6.4 million recorded in Q4 2024.
- Over the past 5 years, Whitehawk Therapeutics' Gross Profit peaked at $14.0 million during Q4 2021, and registered a low of $2.1 million during Q1 2022.
- Over the past 5 years, Whitehawk Therapeutics' median Gross Profit value was $5.4 million (recorded in 2023), while the average stood at $5.6 million.
- In the last 5 years, Whitehawk Therapeutics' Gross Profit crashed by 6425.0% in 2022 and then surged by 15084.59% in 2023.
- Quarter analysis of 5 years shows Whitehawk Therapeutics' Gross Profit stood at $14.0 million in 2021, then tumbled by 64.25% to $5.0 million in 2022, then increased by 7.87% to $5.4 million in 2023, then grew by 19.45% to $6.4 million in 2024, then decreased by 0.99% to $6.4 million in 2025.
- Its last three reported values are $6.4 million in Q1 2025, $6.4 million for Q4 2024, and $6.4 million during Q3 2024.